Electrical Geodesics, Inc.

Electrical Geodesics, Inc. specializes in advanced neuroimaging technologies, focusing on high-density EEG systems that monitor and analyze brain activity for clinical and research applications. Founded in 1992 in Eugene, US, Electrical Geodesics, Inc. develops neuroimaging products.

The company was acquired in July 2020 by The Magstim Company Ltd. , a portfolio company of Telegraph Hill Partners from Koninklijke Philips N. V. The founder's background is not specified in the available information.

Electrical Geodesics, Inc. (EGI) offers advanced neuroimaging products and services focusing on measuring and analyzing brain activity through high-density EEG systems. These systems capture real-time electrical signals generated by neuronal activity and serve clinical diagnostics, neuroscience research, cognitive psychology, and neurofeedback training. EGI's products are utilized in hospitals, academic institutions, and research laboratories across North America and Europe, catering to healthcare professionals, researchers, and educational entities.

Known for their precision, EGI’s EEG systems contribute significantly to understanding brain function and neurological disorders such as epilepsy and dementia. EGI generates revenue through direct sales of its EEG systems and related software and services, operating on a B2B model primarily targeting hospitals, research institutions, and universities. Transactions usually involve significant capital expenditures for the EEG systems, alongside training and support services. Additionally, EGI may provide subscription-based software solutions for data analysis and ongoing technical support, allowing clients access to the latest tools.

The pricing reflects the advanced technology offered, which is essential for accurate brain activity measurement. As part of their growth strategy, EGI is focusing on expanding its products and services line and exploring new markets. The recent acquisition in July 2020 may enhance their capacity to innovate and expand their footprint. The financial terms of the acquisition were not disclosed, but it positions EGI for further development in neuroimaging technologies.

Specific products or expansions have not been detailed, but the company is likely to prioritize enhancing their existing offerings and potentially entering new geographic regions to broaden their customer base.